Vitro Biopharma, Inc. — Form D

Vitro Biopharma, Inc. of GOLDEN, CO, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-11. The offering totals $15.0M, of which $100K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Chris FurmanDirectorGolden, CO
Caroline MosessianDirectorGolden, CO
James MusickDirectorGolden, CO
John PacksDirectorGolden, CO
Chris FurmanExecutive OfficerGolden, CO
Thomas OhrtExecutive OfficerGolden, CO
James MusickExecutive OfficerGolden, CO
Tiana R StatesExecutive OfficerDenver, CO
Nathan HaasExecutive OfficerDenver, CO
Christopher FurmanDirectorDenver, CO
Christopher FurmanExecutive OfficerDenver, CO
John R PacksDirectorDenver, CO
James R MusickDirectorDenver, CO
James R MusickExecutive OfficerDenver, CO
Caroline R MosessianDirectorDenver, CO
Caroline R MosessianExecutive OfficerDenver, CO
JACK ZAMORADirectorDENVER, CO
JACK ZAMORAExecutive OfficerDENVER, CO
John EvansDirectorWest Haven, CT
John EvansExecutive OfficerWest Haven, CT
ERIK D VAN HORNDirectorGolden, CO
ERIK D VAN HORNExecutive OfficerGolden, CO
ERIK VAN HORNDirectorGOLDEN, CO

Other filings by this issuer (8)

FiledFormOfferingSold
2023-12-01D$3.0M$2.0M
2023-04-05D/A$2.5M$993K
2023-01-23D$405K$405K
2021-10-20D$10.0M$3.0M
2020-10-08D/A$3.5M$1.0M
2020-01-23D$1.0M$500K
2010-09-30D$30K$30K
2010-01-06D$88K$88K

More